Skip to main content
SGMO logo
SGMO
(NASDAQ)
Sangamo Therapeutics, Inc.
$0.30-- (--)
Loading... - Market loading

Sangamo Therapeutics (SGMO) Stock Price & Financial Analysis

Sangamo Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.23 - $0.31
52-Week High$0.84
52-Week Low$0.21
Open$0.25
Volume8.77M
Average Volume (3M)8.77M
Market Cap91.31M
Shares Outstanding304.27M
Price to Sales (P/S)2.41
Price to Book (P/B)12.68
EV/EBITDA-0.74
Revenue (TTM)32.88M
Net Income (TTM)-108.91M
Free Cash Flow (TTM)-76.40M
EPS (TTM)$-0.36
Profit Margin-331.28%
Operating Margin-331.64%
Return on Equity (ROE)-1744.50%
Debt to Equity4.07
50-Day MA$0.39
200-Day MA$0.49
52-Week Change-54.38%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Sangamo Therapeutics

What is the current stock price for SGMO?

As of the latest trading session, SGMO stock trades at $0.30. The 52-week range is $0.21–$0.84, with a day range of $0.23–$0.31.

What is the P/E ratio for SGMO?

The P/E ratio (Price-to-Earnings) for SGMO is shown in the Key Statistics section. This valuation metric helps compare Sangamo Therapeutics, Inc. to industry peers.

Does SGMO pay dividends?

Sangamo Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SGMO?

Based on 1 analyst, the consensus for SGMO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SGMO?

Sangamo Therapeutics's market capitalization is $91.3M, classifying it as a micro-cap company. Sangamo Therapeutics operates in the Healthcare sector within the Biotechnology industry.